Items tagged with Global health

Measuring impact of drugs on global health can aid in identifying shortcomings (post)

BINGHAMTON, N.Y., 11-Jan-2022 – A common framework that standardizes health impact across diseases and their interventions can aid in identifying current shortcomings on a global scale, according to new research from Binghamton University, State University of New York.

WHO: Essential health services face continued disruption during COVID-19 pandemic (post)

Geneva, Switzerland, 7 February 2022 – Two years into the pandemic, health systems are still facing significant challenges in providing essential health services. Ongoing disruptions have been reported in over 90% of countries surveyed in the third round of WHO’s Global pulse survey on continuity of essential health services during the COVID-19 pandemic.

Five African presidents launch Global Fund's US$18 billion campaign to restore progress against AIDS, TB and malaria amid COVID-19 disruption (post)

-- Presidents of DRC, Kenya, Rwanda, Senegal and South Africa join global leaders, communities, civil society organizations and private sector partners to kick off the Global Fund’s Seventh Replenishment campaign.
-- US$18 billion would save 20 million lives, cut HIV, TB and malaria deaths by 65% and strengthen health systems to reinforce pandemic preparedness.

Union World Conference on Lung Health announced (post)

The International Union Against Tuberculosis and Lung Disease announced the 53rd Union World Conference on Lung Health which will take place virtually on 8-11 November 2022.

Increase funding or abandon hope of ending malaria, TB and AIDS (post)

Donors at the Seventh Replenishment Preparatory Meeting (23-24 February 2022) were urged to pledge billions of dollars to get the fight against HIV, TB and malaria “back on track” after health systems and key programs were devastated by the impact of the COVID-19 pandemic. The Global Fund warned the meeting’s delegates that unless donors make an unprecedented total funding pledge of at least $18 billion this year, the global goal of ending the three epidemics by 2030 will not be met.

President Biden signals a $6 billion US pledge for the Seventh Replenishment and offers to match $1 for every $2 contributed by other donors (post)

GENEVA, 28 March 2022 – The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes President Joe Biden’s request to the United States Congress for a commitment of US$2 billion for the Global Fund for fiscal year 2023, the first year of the Global Fund’s 2023-2025 funding cycle. President Biden’s fiscal year 2023 budget includes “… a $2 billion contribution for the Global Fund’s Seventh Replenishment, for an intended pledge of $6 billion over three years….” The White House notes that the United States will “match $1 for every $2 contributed by other donors.”

Registration for the upcoming virtual Union World Conference is NOW OPEN (post)

The registration for the 53rd Union World Conference on Lung Health is NOW OPEN! The conference will take place virtually on 8-11 November 2022.

Community Connect submissions are now open (post)

Community Connect is a valuable addition and important highlight of the Union World Conference on Lung Health 2022 which will take place virtually on 8-11 November 2022. Representatives of the affected community and civil society come together to share experiences and develop solutions on issues surrounding lung health.

Drug makers must address access to antibiotics to help slow the superbug threat (post)

New report sets out six case studies of drug makers that are increasing local access to antibiotics and antifungals, including through technology transfers and partnerships. People in low- and middle-income countries cannot get the antibiotics and antifungal medicines they need. This is fuelling the spread of drug resistance.

GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries (post)

• New investment supports further innovation in malaria, tuberculosis, and HIV, with a new emphasis on Neglected Tropical Diseases and anti-microbial resistance
• GSK Global Health R&D Hubs are progressing more than 30 potential new vaccines and medicines, targeting 13 high-burden infectious diseases
• GSK will also maintain donations of albendazole until the elimination of lymphatic filariasis, and double production of its adjuvant for use in the RTS,S malaria vaccine
• New commitments support GSK’s ambition to positively impact the health of more than 2.5 billion people in the next ten years

23 June 2022, London UK: GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate research and development (R&D) dedicated to infectious diseases that disproportionately impact lower-income countries.